Clinical Trials in Jiujiang, China
9 recruiting
Showing 1–20 of 22 trials
Recruiting
Phase 3
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Small for Gestational Age
Xiamen Amoytop Biotech Co., Ltd.141 enrolled49 locationsNCT07309562
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
UCB Biopharma SRL450 enrolled225 locationsNCT06617325
Recruiting
Phase 2
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
AstraZeneca320 enrolled144 locationsNCT07276581
Recruiting
Phase 3
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
Acute Ischemic Stroke
Boehringer Ingelheim1,325 enrolled224 locationsNCT07361302
Recruiting
Not Applicable
The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases
Cardiovascular Diseases
AstraZeneca3,000 enrolled84 locationsNCT06909773
Recruiting
Phase 3
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease
Respiratory Syncytial Virus Infections
GlaxoSmithKline750 enrolled13 locationsNCT07220109
Recruiting
Phase 2
Phase II Study of RC1416 Injection in COPD
Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Nanjing RegeneCore Biotech Co., Ltd.180 enrolled41 locationsNCT07402551
Recruiting
Not Applicable
CAS for Stenosis With High-risk Features for CEA
Carotid artery stentingCarotid Artery Stenosis
Beijing Tiantan Hospital212 enrolled16 locationsNCT07370246
Recruiting
Phase 3
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
AbbVie1,000 enrolled369 locationsNCT05843643
Recruiting
Phase 2
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.195 enrolled29 locationsNCT07252908
Recruiting
China HeadAche DIsorders RegiStry
Tension-type headacheMigraineHeadache Disorders, Primary+3 more
Beijing Tiantan Hospital10,000 enrolled20 locationsNCT05334927
Recruiting
Phase 3
Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window
Stroke, Acute Ischemic
Xinqiao Hospital of Chongqing820 enrolled4 locationsNCT06987305
Recruiting
Phase 3
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
Acute Ischemic Stroke
Second Affiliated Hospital of Guangxi Medical University348 enrolled38 locationsNCT05604638
Recruiting
Phase 2
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Mabwell (Shanghai) Bioscience Co., Ltd.360 enrolled51 locationsNCT07292714
Recruiting
Phase 3
Normobaric Oxygen in AIS Transferred for EVT
Ischemic Stroke
Capital Medical University1,500 enrolled112 locationsNCT06666764
Recruiting
Phase 4
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
CKD (Chronic Kidney Disease) Stage 5D
Guangdong Provincial People's Hospital9,000 enrolled139 locationsNCT04381143
Recruiting
Phase 3
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd.552 enrolled62 locationsNCT06775860
Recruiting
Phase 1Phase 2
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
System Lupus Erythematosus
Sinocelltech Ltd.168 enrolled14 locationsNCT06841042
Recruiting
Not Applicable
Single-layer Robot-assisted Transperitoneal Retroperitoneal Tubeless Radical Nephrectomy
Renal CancerNonfunctional Kidney
The First People's Hospital of Xiushui150 enrolled1 locationNCT06565598
Recruiting
Phase 2
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Beijing InnoCare Pharma Tech Co., Ltd.186 enrolled41 locationsNCT05688696